Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

TAC regimen

View Patient Information

A regimen consisting of docetaxel, doxorubicin and cyclophosphamide that can be used in the treatment of breast cancer.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	docetaxel/doxorubicin/cyclophosphamide docetaxel/doxorubicin/cyclophosphamide regimen TAC taxotere-Adriamycin-Cytoxan regimen

TAC regimen

Search NCI's Drug Dictionary